WallStSmart

Garden Stage Limited Ordinary Shares (GSIW)vsMorgan Stanley (MS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Morgan Stanley generates 904679% more annual revenue ($73.17B vs $8.09M). MS leads profitability with a 24.7% profit margin vs -93.2%. MS earns a higher WallStSmart Score of 71/100 (B).

GSIW

Avoid

28

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 7.0
Piotroski: 4/9Altman Z: -0.56

MS

Strong Buy

71

out of 100

Grade: B

Growth: 9.3Profit: 7.5Value: 4.3Quality: 4.0
Piotroski: 5/9Altman Z: 0.38

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GSIW3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
414.6%10/10

Revenue surging 414.6% year-over-year

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

MS5 strengths · Avg: 9.0/10
Market CapQuality
$339.08B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
40.6%10/10

Strong operational efficiency at 40.6%

Profit MarginProfitability
24.7%9/10

Keeps 25 of every $100 in revenue as profit

Revenue GrowthGrowth
16.3%8/10

16.3% revenue growth

EPS GrowthGrowth
31.9%8/10

Earnings expanding 31.9% YoY

Areas to Watch

GSIW4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$45.03M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-49.7%2/10

ROE of -49.7% — below average capital efficiency

Free Cash FlowQuality
$-3.41M2/10

Negative free cash flow — burning cash

MS4 concerns · Avg: 1.8/10
PEG RatioValuation
2.542/10

Expensive relative to growth rate

Free Cash FlowQuality
$-7.85B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.382/10

Distress zone — elevated risk

Debt/EquityHealth
3.451/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : GSIW

The strongest argument for GSIW centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 414.6% demonstrates continued momentum.

Bull Case : MS

The strongest argument for MS centers on Market Cap, Operating Margin, Profit Margin. Profitability is solid with margins at 24.7% and operating margin at 40.6%. Revenue growth of 16.3% demonstrates continued momentum.

Bear Case : GSIW

The primary concerns for GSIW are EPS Growth, Market Cap, Return on Equity.

Bear Case : MS

The primary concerns for MS are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 3.45 is elevated, increasing financial risk.

Key Dynamics to Monitor

GSIW profiles as a hypergrowth stock while MS is a growth play — different risk/reward profiles.

GSIW carries more volatility with a beta of 4.00 — expect wider price swings.

GSIW is growing revenue faster at 414.6% — sustainability is the question.

GSIW generates stronger free cash flow (-3M), providing more financial flexibility.

Bottom Line

MS scores higher overall (71/100 vs 28/100), backed by strong 24.7% margins and 16.3% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Garden Stage Limited Ordinary Shares

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Garden Stage Limited Ordinary Shares (GSIW) stands at the forefront of the sustainable gardening and horticulture industry, offering innovative eco-friendly solutions tailored for both amateur and professional gardeners. Committed to resource management and organic practices, GSIW aligns its operations with the increasing global demand for sustainable living. The company's strong emphasis on research and development enables it to incorporate advanced technologies, solidifying its competitive edge in a rapidly evolving market. As consumer preferences shift towards environmentally responsible choices, GSIW represents a strategic investment opportunity for institutional investors aiming to diversify their portfolios with sustainable assets.

Visit Website →

Morgan Stanley

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City.

Want to dig deeper into these stocks?